Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 1/2020

09.01.2020 | original report

Epidemiology and predictors of survival of tongue cancer among Egyptians in the Delta region

verfasst von: Omar Hamdy, Mahmoud M. Saleh, Mohammed H. Ros, Amir Mosaad, Shadi Awny, Engy M. Abo-Elnaga, Islam H. Metwally

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Tongue cancer is one of the most aggressive oral cavity malignancies. It is more common in Southeast Asia. Epidemiology in Africa and Arab countries is not well studied. Herein the authors searched the hospital-based registry for tongue cancer patients whether surgically treated or not. The authors retrieved 156 cases eligible for the study. The tumour mainly affected older individuals with a male to female ratio of 1.04:1. Most of the patients received surgical treatment mainly partial or hemiglossectomy with either elective or therapeutic neck dissection. Overall survival was affected by age and recurrence, while disease-free survival was affected by age, grade, T stage, lymph node status, type of surgery and adjuvant therapy. In conclusion, population based registries are needed to further quantify the risk of disease in Africa and the Middle East. In addition, high treatment failure after classic treatment of tongue cancer warrants further research in identifying underlying aetiology and implementing neoadjuvant and adjuvant therapy in the treatment tools.
Literatur
1.
Zurück zum Zitat Curado M‑P, et al. Cancer incidence in five continents. Vol. 6. Lyon, France: IARC Press, International Agency for Research on Cancer; 2007. Curado M‑P, et al. Cancer incidence in five continents. Vol. 6. Lyon, France: IARC Press, International Agency for Research on Cancer; 2007.
2.
Zurück zum Zitat Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–16. CrossRef Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–16. CrossRef
3.
Zurück zum Zitat Llewellyn C, Johnson N, Warnakulasuriya K. Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review. Oral Oncol. 2001;37(5):401–18. CrossRef Llewellyn C, Johnson N, Warnakulasuriya K. Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review. Oral Oncol. 2001;37(5):401–18. CrossRef
4.
Zurück zum Zitat Idris A, et al. Descriptive epidemiology of oral neoplasms in sudan 1970–1985 and the role of toombak. Int J Cancer. 1995;61(2):155–8. CrossRef Idris A, et al. Descriptive epidemiology of oral neoplasms in sudan 1970–1985 and the role of toombak. Int J Cancer. 1995;61(2):155–8. CrossRef
5.
Zurück zum Zitat Al-Jaber A, Al-Nasser L, El-Metwally A. Epidemiology of oral cancer in Arab countries. SMJ. 2016;37(3):249. CrossRef Al-Jaber A, Al-Nasser L, El-Metwally A. Epidemiology of oral cancer in Arab countries. SMJ. 2016;37(3):249. CrossRef
6.
Zurück zum Zitat Rubin P, McDonald S, Qazi R. Clinical oncology: a multidisciplinary approach for physicians and students. 1993. Rubin P, McDonald S, Qazi R. Clinical oncology: a multidisciplinary approach for physicians and students. 1993.
7.
Zurück zum Zitat Warnakulasuriya K, Robinson D, Evans H. Multiple primary tumours following head and neck cancer in southern England during 1961–98. J Oral Pathol Med. 2003;32(8):443–9. CrossRef Warnakulasuriya K, Robinson D, Evans H. Multiple primary tumours following head and neck cancer in southern England during 1961–98. J Oral Pathol Med. 2003;32(8):443–9. CrossRef
8.
Zurück zum Zitat Attar E, et al. Head and neck cancer in a developing country: a population-based perspective across 8 years. Oral Oncol. 2010;46(8):591–6. CrossRef Attar E, et al. Head and neck cancer in a developing country: a population-based perspective across 8 years. Oral Oncol. 2010;46(8):591–6. CrossRef
9.
Zurück zum Zitat Sankaranarayanan R, et al. Oral cancer: prevention, early detection, and treatment. In: Cancer: disease control priorities. 3rd ed. 2015. p. 85. Sankaranarayanan R, et al. Oral cancer: prevention, early detection, and treatment. In: Cancer: disease control priorities. 3rd ed. 2015. p. 85.
10.
Zurück zum Zitat Ng JH, et al. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck. 2017;39(2):297–304. CrossRef Ng JH, et al. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck. 2017;39(2):297–304. CrossRef
11.
Zurück zum Zitat Pezzuto F, et al. Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies. Oncology. 2015;89(3):125–36. CrossRef Pezzuto F, et al. Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies. Oncology. 2015;89(3):125–36. CrossRef
12.
Zurück zum Zitat Veness MJ, et al. Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients? ANZ J Surg. 2005;75(3):101–5. CrossRef Veness MJ, et al. Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients? ANZ J Surg. 2005;75(3):101–5. CrossRef
13.
Zurück zum Zitat Licitra L, et al. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol. 2003;21(2):327–33. CrossRef Licitra L, et al. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol. 2003;21(2):327–33. CrossRef
14.
Zurück zum Zitat Bossi P, et al. Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial. Ann Oncol. 2014;25(2):462–6. CrossRef Bossi P, et al. Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial. Ann Oncol. 2014;25(2):462–6. CrossRef
15.
Zurück zum Zitat Liao CT, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol. 2008;15(3):915–22. CrossRef Liao CT, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol. 2008;15(3):915–22. CrossRef
16.
Zurück zum Zitat Ansarin M, et al. Classification of GLOSSECTOMIES: proposal for tongue cancer resections. Head Neck. 2019;41(3):821–7. CrossRef Ansarin M, et al. Classification of GLOSSECTOMIES: proposal for tongue cancer resections. Head Neck. 2019;41(3):821–7. CrossRef
17.
Zurück zum Zitat Mannelli G, et al. Classification of tongue cancer resection and treatment algorithm. J Surg Oncol. 2018;117(5):1092–9. CrossRef Mannelli G, et al. Classification of tongue cancer resection and treatment algorithm. J Surg Oncol. 2018;117(5):1092–9. CrossRef
18.
Zurück zum Zitat Lee DY, et al. Survival and recurrence of resectable tongue cancer: resection margin cutoff value by T classification. Head Neck. 2018;40(2):283–91. CrossRef Lee DY, et al. Survival and recurrence of resectable tongue cancer: resection margin cutoff value by T classification. Head Neck. 2018;40(2):283–91. CrossRef
19.
Zurück zum Zitat Mücke T, et al. Tumor thickness and risk of lymph node metastasis in patients with squamous cell carcinoma of the tongue. Oral Oncol. 2016;53:80–4. CrossRef Mücke T, et al. Tumor thickness and risk of lymph node metastasis in patients with squamous cell carcinoma of the tongue. Oral Oncol. 2016;53:80–4. CrossRef
20.
Zurück zum Zitat Thiagarajan S, et al. Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol. 2014;109(7):639–44. CrossRef Thiagarajan S, et al. Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol. 2014;109(7):639–44. CrossRef
Metadaten
Titel
Epidemiology and predictors of survival of tongue cancer among Egyptians in the Delta region
verfasst von
Omar Hamdy
Mahmoud M. Saleh
Mohammed H. Ros
Amir Mosaad
Shadi Awny
Engy M. Abo-Elnaga
Islam H. Metwally
Publikationsdatum
09.01.2020
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-00557-0